Small-Molecule PROTACs for Cancer Immunotherapy

Unsatisfactory physicochemical properties of macromolecular drugs seriously hinder their application in tumor immunotherapy. However, these problems can be effectively solved by small-molecule compounds. In the promising field of small-molecule drug development, proteolysis targeting chimera (PROTAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zefan, Zhang, Yajun, Xiang, Yucheng, Kang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458232/
https://www.ncbi.nlm.nih.gov/pubmed/36080223
http://dx.doi.org/10.3390/molecules27175439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458232/
https://www.ncbi.nlm.nih.gov/pubmed/36080223
http://dx.doi.org/10.3390/molecules27175439

Ejemplares similares